Notice 2023-63: Guidance on application of section 174

Interim guidance intended to clarify the application of section 174

Interim guidance intended to clarify the application of section 174

The IRS today released an advance version of Notice 2023-63 [PDF 271 KB] providing interim guidance intended to clarify the application of section 174, as amended by Pub. L. No. 115-97 (commonly referred to as the “Tax Cuts and Jobs Act” (TCJA)).

The notice includes guidance addressing:

  • Capitalization and amortization of specified research or experimental (SRE) expenditures under section 174, as amended
  • Treatment of SRE expenditures under section 460
  • Application of section 482 to cost sharing arrangements involving SRE expenditures

The notice also announces that the Treasury Department and the IRS intend to issue proposed regulations providing rules consistent with the guidance in the notice applicable for tax years ending after September 8, 2023, and until then taxpayers may rely on the interim guidance in the notice, provided the taxpayer applies all of the rules in a consistent manner. However, taxpayers may not rely on the rules in section 7 of the notice for SRE expenditures paid or incurred with respect to property that is contributed to, distributed from, or transferred from a partnership.

The notice further announces that the Treasury Department and IRS intend to issue guidance providing procedures for taxpayers to obtain automatic consent to change methods of accounting to comply with the notice, and until then taxpayers may rely on section 7.02 of Rev. Proc. 2023- 24 to change their methods of accounting under section 174 to comply with the notice. The Treasury Department and IRS anticipate issuing updated procedures that will address situations in which taxpayers have, prior to the issuance of the notice, changed methods of accounting to comply with section 174 as amended by the TCJA but whose treatment of SRE expenditures is not entirely consistent with the notice.

The notice specifically states that the guidance in the notice does not apply for purposes of determining whether an expenditure paid or incurred for taxable years beginning before January 1, 2022, is a research or experimental expenditure under section 174 as in effect for tax years beginning before January 1, 2022. In addition, the notice provides guidance regarding expenditures that are treated as SRE expenditures under section 174 and, therefore, affects expenditures that may be treated as SRE expenditures for purposes of section 41(d)(1)(A) and Treas. Reg. § 1.41-4(a)(2)(i), but the notice is not intended to change the rules for determining eligibility for or computation of the research credit under section 41, including rules for “research with respect to computer software,” and the definitions of “qualified research” and “qualified research expenses.”

Comments on the notice are generally requested, along with comments on specific issues and issues not addressed in the notice. 

 

The KPMG name and logo are trademarks used under license by the independent member firms of the KPMG global organization. KPMG International Limited is a private English company limited by guarantee and does not provide services to clients. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm. The information contained herein is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavor to provide accurate and timely information, there can be no guarantee that such information is accurate as of the date it is received or that it will continue to be accurate in the future. No one should act on such information without appropriate professional advice after a thorough examination of the particular situation. For more information, contact KPMG's Federal Tax Legislative and Regulatory Services Group at: + 1 202 533 3712, 1801 K Street NW, Washington, DC 20006.